These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1053788)

  • 1. Evidence that 5-methoxy-N, N-dimethyl tryptamine is a specific substrate for MAO-A in the rat: implications for the indoleamine dependent behavioural syndrome.
    Squires RF
    J Neurochem; 1975 Jan; 24(1):47-50. PubMed ID: 1053788
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.
    Waldmeier PC; Maître L
    Psychopharmacology (Berl); 1977 Apr; 52(2):137-44. PubMed ID: 407597
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.
    Grahame-Smith DG
    Br J Pharmacol; 1971 Dec; 43(4):856-64. PubMed ID: 4261561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ; Marsden CA; Martin KF; Palfreyman MG
    Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT-mediated myoclonus in the guinea pig as a model of brainstem 5-HT and tryptamine receptor action.
    Luscombe G; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():529-43. PubMed ID: 2418649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigs.
    Luscombe G; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Jun; 32(12):1857-64. PubMed ID: 6192824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the behavioral effects of proteo-and deutero-N, N-dimethyltryptamine.
    Beaton JM; Barker SA; Liu WF
    Pharmacol Biochem Behav; 1982 May; 16(5):811-4. PubMed ID: 6806829
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioural changes induced by N,N-dimethyl-tryptamine in rodents.
    Jenner P; Marsden CD; Thanki CM
    Br J Pharmacol; 1980 May; 69(1):69-80. PubMed ID: 6769527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsynaptosomal distribution, inhibition, and characterization of the binding of (14C) 5-OH-indole-3-acetaldehyde to brain preparations.
    Ungar F; Alivisatos SG
    Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):449-64. PubMed ID: 7005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals.
    Gillin JC; Tinklenberg J; Stoff DM; Stillman R; Shortlidge JS; Wyatt RJ
    Biol Psychiatry; 1976 Jun; 11(3):355-8. PubMed ID: 820383
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence from behavioural reactions to fenfluramine, 5-hydroxytryptophan, and 5-methoxy-N,N-dimethyltryptamine for differential effects of short-term and long-term lithium on indoleaminergic mechanisms in rats [proceedings].
    Harrison-Read PE
    Br J Pharmacol; 1979 May; 66(1):144P-145P. PubMed ID: 313227
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioural changes induced by N,N-dimethyltryptamine in rodents [proceedings].
    Jenner P; Marsden CD; Thanki CM
    Br J Pharmacol; 1978 Jun; 63(2):380P. PubMed ID: 276408
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolism of indolealkylamines by type A and B monoamine oxidase of brain.
    Neff NH; Yang HY; Goridis C; Bialek D
    Adv Biochem Psychopharmacol; 1974; 11(0):51-8. PubMed ID: 4845688
    [No Abstract]   [Full Text] [Related]  

  • 14. An interaction between the antidepressant drugs desipramine and modaline sulphate.
    Jori A; Pugliatti C
    J Pharm Pharmacol; 1967 Dec; 19(12):853-5. PubMed ID: 4383656
    [No Abstract]   [Full Text] [Related]  

  • 15. The nature of inhibition of thyroid monoamine oxidase by thyroxine in rat thyroid.
    Knopp J
    Endokrinologie; 1982 Nov; 80(3):367-70. PubMed ID: 7166166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Excitormotor effects of tryptamine, in presence of IMAO, in mice pretreated with enzymatic inducers].
    Denys A; Levy J; Michel-Ber E
    Therapie; 1969; 24(5):907-22. PubMed ID: 4391432
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P; Artigas F
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monoamine oxidase inhibitors on the borohydride stabilizable binding of serotonin and tryptamine in brain.
    Ungar F; Callaghan OH
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):191-9. PubMed ID: 877408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systems.
    Luscombe G; Jenner P; Marsden CD
    Neuropharmacology; 1982 Dec; 21(12):1257-65. PubMed ID: 6130489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does potentiation of the excito-motor effects of tryptamine in the rat and mouse enable one to measure the action of monoamine oxidase inhibitors?].
    Denys A; Levy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):457-74. PubMed ID: 5850025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.